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Abstract
Background: Pluripotent stem cells that are capable of differentiating into different cell types and develop robust
hallmark cellular features are useful tools for clarifying the impact of developmental events on neurodegenerative
diseases such as Huntington’s disease. Additionally, a Huntington’s cell model that develops robust pathological
features of Huntington’s disease would be valuable for drug discovery research.
Results: To test this hypothesis, a pluripotent Huntington’s disease monkey hybrid cell line (TrES1) was established
from a tetraploid Huntington’s disease monkey blastocyst generated by the fusion of transgenic Huntington’s
monkey skin fibroblast and a wild-type non-transgenic monkey oocyte. The TrES1 developed key Huntington’s
disease cellular pathological features that paralleled neural development. It expressed mutant huntingtin and stem
cell markers, was capable of differentiating to neural cells, and developed teratoma in severely compromised
immune deficient (SCID) mice. Interestingly, the expression of mutant htt, the accumulation of oligomeric mutant
htt and the formation of intranuclear inclusions paralleled neural development in vitro , and even mutant htt was
ubiquitously expressed. This suggests the development of Huntington’s disease cellular features is influenced by
neural developmental events.
Conclusions: Huntington’s disease cellular features is influenced by neural developmental events. These results are
the first to demonstrate that a pluripotent stem cell line is able to mimic Huntington’s disease progression that
parallels neural development, which could be a useful cell model for investigating the developmental impact on
Huntington’s disease pathogenesis.
Background
Huntington’s disease (HD) is an autosomal dominant
neurological disorder caused when the CAG expansions
encode the polyglutamine (polyQ) stretches at the N-
terminus of the huntingtin (htt) protein [1]. HD is a
devastating disorder that results in motor dysfunction,
psychiatric disturbances and cognitive impairment. Typi-
cally, HD patients progress to their death 15 to 20 years
after the onset of symptoms at mid-life. However, the
age of onset is highly correlated to the size of polyQ,
while CAG repeats below 37 are considered unaffected.
Key neuropathological features can be found in the
striatal region, specifically the medial spiny neurons
where neurodegeneration can also be observed
throughout the central nervous system. Unique HD
pathology is characterized by the accumulation of oligo-
meric mutant htt, the formation of intranuclear inclu-
sions (NIs), neuropil aggregates and progressive
neuronal death.
Although htt plays a crucial role in early embryogen-
esis [2,3], the functions of htt remain largely unknown.
The role of htt in neural development is intriguing since
htt is widely expressed in the body with its highest levels
of expression in the brain and testis, while the primary
s i t eo fd a m a g e si nH Da r ef o u n di nt h eb r a i n[ 4 - 7 ] .I n
order to clarify the mechanism of neural specific degen-
eration and the impact of cell types on HD pathogen-
esis, pluripotent stem cells that are capable of
differentiating into multiple cell lineages are a unique
model for studying cell and tissue specific pathogenesis
of HD.
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ated using human embryos [8] or by induced pluripo-
tency using HD patients skin cells [9]. These hHD-ES
cell lines are unique resources for studying HD; how-
ever, follow up study has been limited. Although hHD-
ES cells carry mutant htt, the pathological sequence is
expected to follow a similar time-course in HD patients,
typically developing during mid-life. So far, no good HD
cell model has yet been reported that develops hallmark
HD cellular pathological features paralleling neural
development. The latest development of transgenic HD
monkeys suggests that N-terminal fragments of htt and
expanded polyQ can accelerate the onset of HD in
higher primates with distinctive neuropathological and
cognitive behavioral characteristics [10]. The purpose of
the study is to develop a pluripotent stem cell model for
studying the mechanism of HD and the impact of devel-
opmental events on HD pathogenesis, which could also
be used as a platform for drug discovery research and
the development of new treatments. Because of the
development of robust HD features in transgenic HD
monkeys, we expect a pluripotent primate stem cell line
with small htt fragments and expanded polyQ may lead
to the development of hallmark HD cellular pathology
that parallels neural development.
Although there is an immediate need for a pluripotent
stem cell model that develops HD cellular phenotypes
that parallel neural differentiation for studying HD
pathogenesis, the use of nuclear transplantation derived
stem cells has been limited by low efficiency [11]. While
induced pluripotency is a promising method, only one
study on induced pluripotent thesus macaque stem cells
has been reported, which forced us to consider an alter-
native strategy to derive pluripotent HD monkey stem
cells [12]. We have established a pluripotent HD mon-
key hybrid stem cell line, TrES1, that replicates the
impact of mutant htt during the course of in vitro neu-
ronal development. TrES1 was created by using a tetra-
ploid embryo generated by the fusion of a transgenic
HD monkey skin fibroblast with a wild-type non-trans-
genic (WT)-monkey oocyte. Using this TrES1, we have
demonstrated the progressive development of HD hall-
mark cellular features that parallel neuronal develop-
ment in vitro in higher primate pluripotent stem cells
for the first time.
Results
Characterization of HD monkey skin fibroblast
Skin cells were isolated from a miscarried male trans-
genic HD monkey (rHD) at four months of gestation.
rHD was confirmed transgenic with mutant htt and
GFP gene by PCR (Figure 1A). A total of 72 CAG
repeats were confirmed in the transgenic mutant htt
gene, which was identical to the parent skin fibroblast.
The expression of mutant htt was confirmed by Wes-
tern blot and immunohistochemistry with mEM48, a
monoclonal antibody whose reaction with human htt is
enhanced by polyQ expansion [10]. Western blotting of
brain and peripheral tissues demonstrated the presence
of oligomeric htt at high molecular weight (>250 kD) in
the upper portion of a gradient polyacrylamide gel (Fig-
ure 1B; Arrow). Oligomeric mutant htt was presented in
the peripheral tissues (Figure 1B) and brain (Figure 1B)
of rHD but not in WT-monkeys. The extent of expres-
sion and aggregation levels of mutant htt was observed
among peripheral tissues (Figure 1B), while only some
skin cells developed htt aggregates and NIs (Figure 1C).
Generation of HD monkey tetraploid embryo and
derivation of a hybrid cell line
The primary cultured skin cells of rHD were used to
derive tetraploid embryos by fusion with mature WT-
monkey oocytes. The first polar body (PB) was removed
through a pre-cut zona-pellucida (ZP; Figure 2A-a and
2A-b) and a skin cell was placed under the ZP (Figure
2A-c) followed by electrofusion (Figure 2A-d) to create
a hybrid embryo. The reconstructed hybrid embryos
were chemically activated and cultured until blastocyst
stage for the derivation of ES cells (Figure 2B).
Two out of four reconstructed HD monkey hybrid
embryos were developed to blastocyst. The hybrid blas-
tocysts (Figure 2B-a) were placed onto mouse fetal
fibroblast (MFF) feeder cells and allowed to form an
outgrowth (Figure 2B-b). At 14 to 16 days, one of the
blastocysts developed an outgrowth with ES cell like
morphology (large nucleus and a high nuclear to cyto-
plasmic ratio) (Figure 2B-b). An ES cell like region was
mechanically dissected and cultured. The resultant HD
monkey hybrid cell line, named TrES1, retains monkey
ES cell morphology (Figure 2B-c) and is pluripotent.
Cytogenetic analysis confirmed that TrES1 is a tetra-
p l o i dh y b r i dc e l ll i n ew i t ht h r e e“X” chromosomes and
one “Y” chromosome (Figure 2C), which suggested that
as e to f“XY” chromosome was derived from skin cell of
r H Dw h i l eas e to f“XX” chromosome was derived from
the monkey oocyte.
Inheritance of mutant htt and GFP genes in TrES1
was confirmed by PCR analysis while these transgenes
can only be derived from rHD but not from the WT-
monkey oocyte.
Genetic identity analysis
Microsatellite analysis and comparison of its mitochon-
drial sequence were used to determine the genetic iden-
tity of TrES1. In all genotyping assays, all alleles
presented in HD monkey skin cells and the lymphocytes
of oocyte donor were also presented in TrES1 (Table 1).
This suggested that TrES1 is a tetraploid and contain
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donor, thus TrES1 is a true hybrid cell line.
For DNA comparisons of the mitochondrial sequence,
16 rhesus macaque specific single nucleotide poly-
morphisms (SNPs) were analyzed. In all 16 cases the
TrES1 matched the oocyte donor but not the rHD skin
cells (Table 2), conclusively showing that the mitochon-
dria present within the hybrid line were inherited from
the female monkey who donated the oocyte that created
the hybrid embryo that was used for the derivation of
TrES1. This result is consistent with a prior study in
somatic cell nuclear transplantation (SCNT) that mito-
chondria inheritance of reconstructed embryos is pri-
marily derived from recipient oocytes instead of the
donor cell nuclei [11].
Stem cell properties and pluripotency
To determine the stem cell properties of TrES1, immu-
nostaining of common monkey ES cell markers was
used. TrES1 expressed alkaline phosphatase (AP), Oct4,
and stem cell specific surface antigens (SSEA4 and
TRA-1-60; Figure 2D).
To determine the pluripotency of TrES1, in vitro dif-
ferentiation to neural cells was performed. A step-wise
differentiation protocol was used in this study while
immunostaining was performed at different stages to
confirm successful differentiation [13]. The expression
of nestin was observed at N2 stage when selective
expansion of neural progenitor cells (NPCs) occurred
(Figure 3). In general, one week induction for neuronal
maturation was suggested at N3 stage (N3-1w). In order
to mimic mature neurons in adult brains that are pri-
marily maintained at a post-mitotic stage, we have
extended N3 culture to four weeks (N3-4w) to deter-
mine if extended culture impacted the mutant htt asso-
ciated phenotype. Glial fibrillary acidic protein (GFAP),
a glial cell marker and neural specific bIII tubulin, was
detected by immunostaining at both N3-1w and N3-4w
stages (Figure 3), which suggested TrES1 was capable of
differentiating to mature neuronal cell types. Although
the expression of mutant htt does not seem to affect
neural differentiation of TrES1, potential effects of
mutant htt on differentiation toward specific neuronal
or peripheral cell types cannot be excluded and further
investigation is necessary. Furthermore, the expression
of GFP was observed at all stages (Figure 3).
Expression of mutant htt in TrES1 derived neuronal
differentiation
To determine if the expression of mutant htt and the
development of HD specific cellular pathology are
related to the course of neural development, the expres-
sion patterns of mutant htt, the accumulation of mutant
htt aggregate, the presence of oligomeric mutant htt and
the formation of NIs were examined by quantitative real
time PCR (Q-PCR), Western blot, immunostaining and
cell count at various stages during in vitro development.
Q-PCR analysis revealed similar expression levels of
mutant htt in undifferentiated TrES1 and YRES4 (WT-
monkey ES cells) at different differentiation stages
Figure 1 Characterization of HD monkey and HD monkey skin fibroblasts. (A) The presence of transgenes “mutant htt and GFP“ in brain
and peripheral tissues of HD monkey was confirmed by PCR analysis using primer sets specifically for mutant htt (top panel) and for the GFP
gene (bottom panel). (B) Expression of the transgenic mutant HTT was confirmed by Western blot analysis in brain and peripheral tissues using
mEM48 (top panel). Immunoblot revealed high-molecular-mass oligomeric HTT (arrow). The blot was also probed with an antibody to g-tubulin
as an internal control (bottom panel)., Wild-type (WT) non-transgenic monkey. (C) Immunostaining of primary cultured skin fibroblast of
transgenic HD monkey using mEM48 demonstrated that transgenic mutant htt was distributed in the nuclei (arrow; C-c) and intranuclear
inclusions (arrowheads; C-c) were also revealed. Expression of GFP was also revealed by epifluorescent microscopy (d). (C-a) transmission light
image; (C-b) Hoechst DNA staining; (C-c) mEM48 staining; (C-d) epifluorescent light image of GFP; (C-e) overlay image. Scale bar = 5 μm.
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mutant htt was observed in TrES1 at N2, N3-1w and
N3-4w when compared to undifferentiated TrES1 and
YRES4 at respected stages (Figure 4A). However, no dif-
ference was observed in TrES1 at N2, N3-1w and N3-
4w (Figure 4A). The same batch of cell samples was
then used for Western blot analysis. Oligomeric mutant
htt was revealed in TrES1 at N2, N3-1w and N3-4w
s t a g e sb u tn o ti nu n d i f f e r e n t i a t e dT r E S 1a n dY R E S 4a t
any stages (Figure 4B). Furthermore, the extent of oligo-
meric mutant htt was gradually enhanced as TrES1 pro-
gressed during in vitro neuronal differentiation (Figure
4B). While the accumulation of oligomeric mutant htt
increased in differentiating TrES1, oligomeric mutant
htt was substantially increased in N3-4w compared to
N3-1w (Figure 4B). This result suggests the possible
impact of neural development on HD pathogenesis.
In order to determine the impact of mutant htt and
the extent of cellular pathology during the course of
neural development, undifferentiated TrES1, TrES1 at
N2, N3-1w and N3-4w were immunostained with
mEM48. Cells developing mutant htt aggregates and
containing NIs were identified and counted. While the
expression of mutant htt was not detected in undifferen-
tiated TrES1 by immunostaining, the number of mEM48
+ cells was significantly higher in N3-4w (32.2%; 132 ±
42.5; n = 1484) > N3-1wk (8.4%; 30.3 ± 19.4; n = 1078)
> N2 (0.26%; 2 ± 0; n = 1271) (Figure 4C). The mEM48
Figure 2 Establishment of HD hybrid cell line. (A) First polar body of mature rhesus macaque oocyte was removed by gentle squeezing
through a slit of zona pellucida (A-a). Staining of 1
st polar body DNA (arrowhead) and oocyte DNA (arrow) (A-b). HD monkey skin cell was
placed under the zona pellucida (black arrow) (A-c). Reconstructed oocyte with HD monkey skin cell (A-d; yellow arrow) was placed between
two electrodes for electrofusion (A-d). (B) Day 12 hatching blastocyst derived from HD monkey hybrid embryo (B-a; arrow indicated ICM). HD
monkey hybrid blastocyst outgrowth at six days after attached onto feeder cells (B-b). High magnification of selected region (inset) of the ICM
outgrowth (arrowhead). HD monkey hybrid cell line (TrES1) at passage 10 (B-c). (C) G-banding analysis of TrES1. Cytogenetic analysis of TrES1
demonstrated tetraploid chromosome (84; XXXY). (D) Expression of ES-cell specific markers: Alkaline phosphatase, Oct4, SSEA4 and TRA-1-60.
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aggregate, cells with nuclear aggregate and contained
one-to-five, six-to-10, and more than 10 NIs (Figure
4D). The number of TrES1 with nuclear aggregate and
developing one to five pieces of NIs was significantly
increased in N3-4w compared to N3-1w and N2. This
finding was consistent with the Q-PCR and Western
blot analysis, which suggested the expression of mutant
h t tw a sn o td i f f e r e n tb e t w e e nN 2 ,N 3 - 1 wa n dN 3 - 4 w ,
but the accumulation of oligomeric mutant htt increased
as TrES1 continued neuronal differentiation in vitro and
extended culture.
In vivo differentiation of TrES1 in the striatum of SCID
mice
To determine the pluripotency of TrES1 in vivo,u n d i f -
ferentiated TrES1 and TrES1 at the N2 stage (presum-
ably NPCs) were implanted into the striatum of the
contralateral hemisphere of severely compromised
immune deficient (SCID) mice. At four-to-10 weeks
post-implantation, animals were euthanized and their
brains were recovered for morphological analysis (Figure
5) and an immunohistochemistry study using different
antibodies to determine neural differentiation (Figure 6)
and the expression of mutant htt (Figure 5B).
A histological study showed that only the undifferen-
tiated TrES1 implanted hemisphere developed tera-
toma, which contained different tissue types, including
gut-like epithelium (endoderm), muscle (mesoderm)
and neural tissues (ectoderm) (Figure 5A). No tera-
toma was observed at the contralateral hemisphere
where NPCs were implanted (Figure 5B). On the other
hand, an immunohistochemical study revealed the
expression of neuronal markers including nestin,
GFAP and microtubule-associated protein (MAP2)
(Figure 6) in both hemispheres. Consistent with histo-
logical analysis, the hemisphere that was implanted
with undifferentiated TrES1 developed teratoma with
heterogenous expression of neuronal markers suggest-
ing non-neuronal tissues was developed (Figure 6). In
contrast, the hemisphere implanted with TrES1 derived
NPCs homogenously expressed neuronal markers and
was co-labeled with GFP that was only expressed in
TrES1 and the derivative cells (Figure 6). Similar
results were observed in all SCID mice implanted with
both cell types. Although NIs were not observed, a
nuclear aggregate was observed in both hemispheres
( F i g u r e5 B - aa n d5 B - b ) .
Discussion
In this study, we showed that TrES1, a hybrid cell line
of Huntington monkey skin fibroblast and monkey
oocyte, is pluripotent and develops robust HD cellular
features as it progresses during neural development in
vitro. The accumulation of mutant htt aggregates and
the formation of NIs were significantly enhanced and
increased at later stages of neural development while a
relatively lower expression of mutant htt was detected
in undifferentiated TrES1 with no detectable accumula-
tion of mutant htt aggregates and NIs. Our finding is
consistent with HD pathogenesis where neuronal tissues
are the primary targets and post-mitotic neural cells
accumulate oligomeric mutant htt as disease progresses,
whereas peripheral cell and tissue types are expected to
have minimal impact.
A pluripotent cell line with an inherited genetic disor-
d e ri so n eo ft h eb e s tm o d e l sf o ru n d e r s t a n d i n gt h e
underlying mechanism of developmental events in dis-
ease progression [8,9,14,15]. Multipotent differentiation
capabilities of pluripotent cells are particularly intriguing
for the study of neurodegenerative diseases such as HD,
because pathological events specifically target neuronal
cell types where peripheral tissues rarely develop
Table 1 Microsatellite analysis of monkey hybrid stem cells
Locus D9s261 D19s582 D16s403 D4s413 D5s108
Donor 96/105 158/170 171/177 141/152 191/193
Recipient 103/105 167/175 167/169 141/150 179/189
Hybrid 96/103/105 158/167/170/175 167/169/171/177 141/150/152 179/189/191/193
Locus D2s146 D3s1768 D6s493 D7s513 D13s1371
Donor 213/221 230/230 272/328 195/208 145/153
Recipient 208/210 210/226 266/269 193/193 169/174
Genotypes for 10 loci were assayed on genomic DNA of HD monkey skin cells, lymphocyte of monkey oocyte donor and TrES1. All alleles present in the skin
fibroblasts and oocyte donor are presented in TrES1, indicating TrES1 is a hybrid of HD monkey skin cell and monkey oocyte.
Table 2 Mitochondrial sequence analysis of monkey
hybrid stem cells
*** *
Donor TTG G CA CAA A CA CTA C AA CAA G AGG
Recipient TTG A CA CAA G CA CTA T AA CAA C AGG
Hybrid TTG A CA CAA G CA CTA T AA CAA C AGG
Mitochondrial sequence comparisons of HD monkey skin cells, lymphocyte of
monkey oocyte donor and TrES1. The representative example is position 371-
731 of Macaca mulatta NCBI reference sequence NC_005943. Highlighted
regions clearly show mitochondrial inheritance of TrES1, is obtained from the
monkey oocyte.
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able of differentiating into neuronal cell types that
mimic early HD developmental events. Unlike other HD
cell models, either by transient or stable expression of
mutant htt in somatic cells (CHO and 293) or a neuro-
nal cell line (PC12) [18-21], a pluripotent cell line is
capable of replicating the influence of developmental
events and mutant htt on HD pathogenesis that no
other cell model can achieve. Although HD mouse ES
cells [15,22-25] and hHD-ES cells have been established
[8,9], most of these cell lines do not develop robust HD
cellular features that parallel neural differentiation, and
detailed characterization of HD pathogenic features in
hHD-ES cells has not been reported. Therefore, a pluri-
potent cell line such as TrES1, which develops key HD
cellular phenotypes, is a unique cell model for studying
HD and understanding fundamental differences between
neuronal and peripheral cells/tissues in HD pathogen-
esis. Thus unique cell/tissue specific components and
events that lead to differential susceptibility of HD cellu-
lar pathogenesis can be identified. One of the major
concerns of deriving pluripotent stem cells such as
TrES1 by tetrapolid technique is its potential instability
due to the nature of tetraploidy. Thus the development
of diploid HD stem cell lines from diploid embryos or
by mean of nuclear transplantation and iPS technology
is important for future applications such as cell therapy.
The impact of developmental events on the progres-
sion of HD was further suggested by the gradual
increase of the aggregate form of mutant htt as neural
differentiation progresses while the expression levels of
mutant htt remains. The continued accumulation of
mutant htt aggregate and the increase of cells with
intranuclear inclusions in extended neuronal culture
further suggest the potential impact on post-mitotic
neural cells. While this study is the first step in charac-
terizing HD monkey pluripotent stem cells, future devel-
opment of a differentiation protocol toward specific
neuronal cell types and peripheral cell types will facili-
tate the investigation of mutant htt cell type specific
pathogenesis.
Due to ethical reasons, the development of pluripotent
human hybrid cell lines is not an option. Recent success
in developing iPS cells using skin cells of human
patients [9,14]and monkeys [12] has opened a new door
for investigating the potential of personal stem cells.
The present study evolved from our latest success in
developing a transgenic HD monkey model. While
efforts in developing alternative methods for deriving
pluripotent stem cell lines from HD monkeys continue,
TrES1 provides a unique model for investigating the
mechanism of HD pathogenesis and the role of neural
developmental events. Furthermore, a pluripotent cell
line such as TrES1, which develop hallmark HD features
paralleling neural development, is a useful tool for accu-
rate interpretation of therapeutic efficacy of new mole-
cules and compounds. So far, there is no other cell
model that replicates key HD cell pathology in parallel
with the progression of neural development in vitro.
O n ep o s s i b l ee x p l a n a t i o nf o rt h er o b u s tH Dc e l l u l a r
phenotypes in TrES1 could be due to the over-expres-
sion of small htt fragments with expanded polyQ. HD
monkeys that carried similar htt mutants developed HD
clinical features early in life [10], which is consistent
with our findings in TrES1. Thus stem cell lines derived
from hHD patients by either traditional methods using
PGD diagnosed embryos or iPS may not develop robust
HD phenotypes comparable to TrES1 even with
expanded polyQ because of the full-length htt. Studies
in HD mouse models further support our speculation
that full length htt is less toxic compared to small htt
fragments [26-28]. Thus HD patients’ derived stem cell
lines may not be able to develop hallmark cellular
Figure 3 Immunocytochemical analysis of in vitro differentiated
TrES1. TrES1 was differentiated toward neuronal lineage in vitro
using a step-wise differentiation protocol. Antibodies specific for
neural progenitor cells (nestin), glial fibrillary acidic protein (GFAP),
and mutant htt (mEM48) were used for immunostaining at different
differentiation stages: N2, N3-1 week (N3-1w), and N3-4 weeks (N3-
4w). At N2 stage, all cells were stained with Nestin and some were
stained positive with mEM48. At N3-1w and N3-4w, cells were
stained with GFAP, bIII-tubulin and mEM48. First column-brightfield
images; second column-epifluorescent images of GFP; third column-
DNA staining with Hoechst; fourth column-immunostaining with
specific antibodies, and fifth column-overlay images of the third and
fourth columns. Insets are images of selected nuclei with nuclear
inclusions at higher magnification.
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accumulation of cellular defects.
W h i l eah y b r i dc e l ll i n ei sn o tap e r f e c tm o d e l ,w e
have now demonstrated that a pluripotent primate stem
cells could replicate some of the key pathological fea-
tures of HD suggesting the continue effort in developing
a personal stem cell from HD patients by mean of
induced pluripotency or other methods is of great value
as a model for studying HD or as a cell source for ther-
apy. However, the progression of HD phenotypes in
such cell lines may vary because of the constitution of
the mutant htt gene and human cell lines with full
length htt and extended CAG repeat may require addi-
tional time to develop pathological features of HD.
Conclusions
A pluripotent tetraploid Huntington’s monkey stem cell
line (TrES1) was derived by the fusion of transgenic HD
monkey skin cell and monkey oocyte. TrES1 is the first
primate stem cells that develop key HD cellular features
(accumulation of mutant htt aggregate and the forma-
tion of intranuclear inclusions) paralleling in vitro neural
development. Because of the robust development of HD
phenotypes, TrES1 could be a useful tool for studying
the developmental impact HD and as a platform for
drug discovery research.
Methods
Regimen of follicular stimulation
Female rhesus monkeys exhibiting regular menstrual
cycles were induced with exogenous gonadotropins
[29,30]. The expression of monkey endogenous gonado-
tropins was down regulated at the beginning of mensis
(day one to day two) by daily subcutaneous injections of
Gonadotropin-releasing hormone (GnRH) antagonist
(Antide; Ares Serono, 0.5 mg/kg body weight) for six
days and by twice daily injection of recombinant human
follicle-stimulating hormone [r-FSH: Organon Inc. 30
IU, intramuscular injection (i.m.)] concurrently. This
was followed by the injection of r-FSH + recombinant
human luteinizing hormone (r-hLH; Ares Serono; 30 IU
each, i.m., twice daily) on the last three days. Ultrasono-
graphy was performed on day seven of the stimulation
to confirm follicular responses. An i.m. injection of
Figure 4 Expression pattern of mutant htt in neural differentiated TrES1. (A) Expression levels of mutant htt at various developmental
stages were determined by Q-PCR. YRES4 is a WT-monkey ES cell line and was used as a control. The expression levels of mutant htt in
differentiated TrES1 were significantly increased at N2, N3-1w and N3-4w compared to undifferentiated TrES1 (ES) and YRES4 at all differentiation
stages. Columns with the same letter indicate no significant difference (P > 0.05). (B) Western blot analysis using mEM48 revealed a gradual
increase of oligomeric transgenic mutant htt as TrES1 progresses during neural differentiation (N3-4w > N3-1w > N2) whereas no high molecular
weight mutant htt aggregates was detected in undifferentiated TrES1 or YRES4 at all stages. (C) Increase of cells expressing mutant htt detected
by mEM48 was observed as differentiation progresses. Columns with the same letter indicate no significant difference (P > 0.05). (D) Expression
pattern of mutant htt was categorized into four groups: soluble form, 1-to-5 nuclear inclusions (NIs), six to10 NIs, and more than 10 NIs. Columns
of the same category with the same letter indicate no significant different (P > 0.05).
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(r-hCG; Ares Serono,) was administered for ovulation
induction when there were follicles at 3-4 mm in dia-
meter. In general, r-hCG was administered at approxi-
mately 37 hours prior to oocyte retrieval for optimal
maturation of metaphase II arrested oocytes.
In vitro Maturation (IVM)
Oocytes were matured in modified CMRL-1066 containing
10% heat-inactivated fetal bovine serum (FBS; Hyclone
Laboratories Inc., Logan, UT) supplemented with 40 μg/
mL Sodium pyruvate, 150 μg/mL Glutamine, 550 μg/mL
Calcium lactate, 100 ng/ml estradiol and 3 ug/ml of Pro-
gesterone for up to 36 hours in 35-μl drops of medium
under mineral oil at 37°C with 5% CO2,5 %O 2 and 90% N2.
Generation of transgenic HD monkeys
High titer lentiviruses carryiing (1) exon 1 of human htt
gene with 84 CAG repeats and (2) green fluorescent
protein (GFP) gene under the regulation of human
polyubiquitin C promoter, were injected into the PVS of
metaphase II (MII) arrested monkey oocytes followed by
intracytoplasmic sperm injection (ICSI) [10]. The resul-
tant embryos were transferred into surrogate females for
the generation of transgenic monkeys. Transgenic status
was confirmed by PCR.
Characterization and preparation of donor skin cells
Donor skin cells were primary cultures of skin tissue
derived from miscarried transgenic HD monkey (rHD)
at four months of gestation. The transgenic status of the
skin cells was confirmed by PCR, immunostaining and
Western analysis [10].
Production of transgenic HD monkey tetraploid embryos
MII arrested oocytes were placed in TL-HEPES [31]
with 5 μg/ml of cytochalasin B (Sigma) for 15 minutes.
The 1
st polar body (PB) was gently squeezed out
through a small slit at the zona pellucida (ZP). After
thorough washes of the oocytes, skin cell was placed
Figure 5 Teratoma derived from TrES1 and expression of mutant htt in striatal graft of TrES1. Undifferentiated TrES1 and TrES1 derived
NPCs were implanted into the striatum of SCID mice and recovered at six weeks for morphological and immunohistochemical analysis. (A)
Hematoxylin and eosin staining of teratoma derived from undifferentiated TrES1. (B) Undifferentiated TrES1 (Left hemisphere) and TrES1 derived
NPCs (Right hemisphere) were implanted into contralateral hemispheres of SCID mice. Immunohistochemical staining using mEM48 revealed the
expression of mutant htt in both hemispheres (B-a and B-b). Areas surrounded by interrupted line indicated the locations of the cell graft.
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Page 8 of 12under the ZP. The couplet was fused by electrofusion
using fusion electrodes in 0.3 M Manitol fusion medium
(two direct currents, 30 volts 30 μsec; Electro cell fusion
system LF-101, Nepa Gene Company). The recon-
structed embryos were cultured in medium supplemen-
ted with 50 nM trichostatin A (TSA; Sigma) for 10-12
hours. Two hours after fusion, the reconstructed
embryos were activated by 5 μMI o n o m y c i nf o rf i v e
minutes and then incubated in 2 mM 6-Dimethylamino-
purine (6-DMAP; Sigma) for five hours at 37°C with 5%
CO2,5 %O 2, 90% N2. The reconstructed embryos were
further cultured in HECM 9 medium for eight days with
5% FBS added on Day two of culture. Fresh medium
was replaced every two days.
Establishment and maintenance of Huntington’s monkey
ES cells from tetraploid blastocyst
Tetraploid blastocysts were cultured for ten to 14 days
until attached onto MFFs to form an outgrowth. The
outgrowths, the exhibited prominent stem cell morphol-
ogy, were mechanically removed, transferred onto
freshly prepared MFFs and continued to culture for the
derivation of monkey ES cells. Monkey ES cells were
cultured in medium composed of knockout-Dulbecco’s
modified Eagle’s medium (KO-DMEM) supplemented
with 20% Knock-out Serum Replacement (KSR; Invitro-
gen), 1 mM glutamine, 1% non-essential amino acids
and supplemented with 4 ng/ml of human basic fibro-
blast growth factor (bFGF; Chemicon). The HD monkey
ES cells derived from tetraploid HD monkey embryos
were named, TrES1.
Transgenic status of the HD monkey ES cells
For detecting the htt-84Q gene, ubiquitin forward primer
(5’-GAGGCGTCAGTTTCTTTGGTC-3’)a n dhtt-84Q-R
reverse primer (5’-GCTGGGTCACTCTGTCTCTG-3’)
were used to yield an 818-bp product after amplification
of genomic DNA from the HD monkey tissues. Genomic
DNA (100 ng) from different tissues were subjected to
PCR for 35 cycles at 96°C for 5 min, 96°C for 45 sec, 62°
C for 45 sec, and 72°C for 150 sec, followed by 72°C for 7
min. To determinate the number of CAG repeats in HD
monkeys, the PCR products were sequenced using HD
exon 1-F primer (5’-GGCGACCCTGGAAAAGCTGA-
3’). For GFP gene, ubiquitin forward primer (5’-
GAGGCGTCAGTTTCTTTGGTC-3’)a n dG F P - R
reverse primer (5’-TAGTGGTTGTCGGGCAGCAG-3’)
were used for amplification for 35 cycles at 94°C for 5
min, at 94°C for 30 s, 64°C for 30 s, and 72°C for 20 s, fol-
lowed by 72°C for 5 min, which yielded a product of 869
bp. DNA from WT-monkeys was used as the negative
control, and plasmid htt-84Q and GFP were used as the
positive controls.
Genotyping
Genotyping was executed using a panel of 13 microsa-
tellites, known to be highly polymorphic and possessing
high levels of heterozygosity in other rhesus macaque
populations [32,33]. Primers for each microsatellite were
obtained with one of the standard Applied Biosytems
(AB) five-dye labels. Amplification reactions were per-
formed on AB 9700 thermal cyclers using MgCl2 con-
centrations of either 1.5 mM or 2.0 mM.
Electrophoresis was carried out using an AB 3730
genetic analyzer, with all subsequent genotyping analysis
using Genemapper 4.0. All genotyping was performed
blind, with a positive and negative control included for
each reaction.
Immunostaining of mutant htt
For cell samples, differenti a t e dT r E S 1w e r ef i x e du s i n g
4% paraformaldehyde (PFA) for 15 mins. Then they
were permeabilized and blocked. The sample was next
Figure 6 In vivo differentiation of TrES1. Undifferentiated TrES1
and TrES1 derived NPCs were implanted into contralateral
hemispheres of SCID mice for six weeks. Nestin, GFAP and MAP2
were co-expressed with GFP in both hemispheres with the TrES1
graft while homogenous expression pattern was observed at the
NPCs implanted hemisphere. First column-DNA staining; Second
column-epifluorescent images of GFP; Third column-
Immunostaining using specific antibodies; Fourth column-overlay
images of second and third column. Scale bar = 50 μm.
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Page 9 of 12incubated with primary antibody mEM48 (1:50) followed
by incubation with secondary antibody conjugated with
Alexa Red (Molecular Probe). DNA was counterstained
with Hoechst 33342 (5 μg/ml), mounted in Vectashield
antifade solution (Vector Labs), and sealed with nail pol-
ish. The specimen was examined with an epifluorescent
microscope. For mouse brains, the mice were anesthe-
tized and perfused using 4% PFA. Brain tissues were
post-fixed in 4% PFA overnight at 4°C, transferred to
30% sucrose, stored at 4°C, embedded in Optimal Cut-
ting Temperature (OCT) medium (Sakura) and cut at
50 μm, followed by DAB staining. For DAB staining,
sections were incubated with 0.3% H2O2 for 15 mins,
blocked for one hour, and incubated with mEM48 (1:50)
at 4°C overnight. After washing with DPBS, the brain
sections were processed with avidin-biotin using the
Vectastain Elite ABC kit (Vector Laboratories), and
immediately stained with DAB (Vector Laboratories) for
30-40 secs. Brain sections were mounted on the slides
with mounting media (Sigma), and images were exam-
ined and captured by MetaMorph software (Universal
Imaging).
Immunostaining of stem cell markers
T r E S 1w e r ep l a c e do n t oM F Fi naf o u r - w e l lp l a t ef o l -
lowed by two to three days culture, and was then fixed
in 4% PFA, permeabilized by 1% Triton-X (excluded for
cell surface markers), blocked with 2% BSA and 130
mM glycine in phosphate buffer saline (PBS). After
overnight incubation with primary antibodies [Oct4
(Santa Cruz Biotechnology), SSEA-4 (Chemicon), TRA-
1-60 (Chemicon)] followed by thorough washes, a sec-
ondary antibody conjugated with Alexa Red (Molecular
Probe) was used for detection of the primary antibodies.
DNA was counterstained with Hoechst 33342 (5 μg/ml).
The specimen was examined with an epifluorescent
microscope. Alkaline phosphatase assay was performed
following manufacturer’s instruction (Vector Lab).
Quantitative RT-PCR (Q-PCR) of stemness factors
The total RNA of cell samples was extracted using
RNeasy Mini Kit (Qiagen). RNA quality was determined
by BioPhotometer (Eppendorf). Reverse transcription
was performed by using High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems), and the resulted
cDNA was used for Q-PCR. 2× Power SYBR® Green
PCR Master Mix (Applied Biosystems) was mixed with
specific primers and cDNA, and subjected to the iQ5
real-time PCR detection system (Bio-Rad). for one cycle
at 96°C for 12 mins; then at 96°C for 15 secs and 60°C
for 30 secs for 50 cycles. The specific primers for
mutant htt specific primers were: HD Exon 1-F:
ATGGCGACCCTGGAAAAGCT and HD Exon 1-R:
TGCTGCTGGAAGGACTTGAG. The specific primer
for 18S: 18S F: CGGCTACCACATCCAAGGAA and
18S R: CCTGTATTGTTATTTTTCGTCACTACCT.
Specific-qPCR primer sets targeting stem cell markers
w e r e :O c t4( O c t 4 - F :5 ’-GCA ACC TGG AGA ATT
TGT TCC T-3’ and Oct4-R: 5’-GGG CGA TGT GGC
TGA TCT-3’), Sox2 (Sox2-F: 5’ GCA GGT TGA CAT
CGT TGG TAA T-3’ and Sox2-R: 5’CCC CCC GAA
GTT TGC TGC G 3’), Nanog (Nanog-F: 5’-TGA AGC
ATC CGA CTG TAA AGA ATC-3’ and Nanog-R: 5’-
CAT CTC AGC AGA AGA CAT TTG CA-3’).
Mitochondria Inheritance Analysis
Sequencing primers were designed in primer 3 http://
frodo.wi.mit.edu/ in order to amplify two regions of rhe-
sus mitochondrial DNA (Macaca mulatta NCBI refer-
ence sequence NC_005943). PCRs were performed using
standard amplification reactions on AB 9700 thermal
cyclers using 2.0 mM MgCl2 concentration. PCR pro-
ducts were checked for expected size by electrophoresis
on agarose gels. Shrimp alkaline phosphatase and Exo-
nuclease I were added to remove single strand DNA.
Sequencing reactions were done using AB Big Dye ter-
minator on a 9700 thermal cycler. The reaction was
purified and sequencing reactions were performed on an
AB 3730 genetic analyzer. Subsequent analysis was done
using SeqScape genetic software. Positive and negative
controls were sequenced along with experimental sam-
ples for each region.
Cytogenetic analysis/G-banding analysis
TrES1 at passage 25 was treated with KaryoMax® colce-
mid (Invitrogen) for 20 mins, dislodged with 0.05%
Trypsin-EDTA, centrifuged and resuspended in hypo-
tonic 0.075 M KCl solution for 20 mins. Following cen-
trifugation, the cells were fixed three times in a 3:1 ratio
of methanol to glacial acetic acid. The cell pellet was
resuspended in 1 ml of fixative and stored at 4°C. For
GTL-Banding, the fixed cell suspension was dropped on
wet slides, air dried, and baked at 90°C for one hour.
Slides were immersed in 0.5× Trypsin-EDTA (Invitro-
gen) with two drops of 67 mM Na2HPO4 for 20 to 30
secs, rinsed in distilled water and stained with Leishman
Stain (Sigma) for 90 secs. Twenty metaphases were ana-
lyzed for numerical and structural chromosome
abnormalities using an Olympus BX-40 microscope.
Images were captured, and at least two cells were karyo-
typed using the CytoVysion® digital imaging system
(Applied Imaging).
In vitro differentiation to neuronal lineage
TrES1 cell clumps were cultured in suspension for seven
days for the formation of embryoid bodies (EBs). EBs
were then allowed to attach onto a gelatin coated plate
and cultured in N1 medium for seven days, N2 medium
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differentiation into mature neuronal cell types. A four
weeks extended culture at N3 stage was added to
enhance maturation of neurons and mimic post-mitotic
condition in the brain. The N1 medium was composed
of KO-DMEM (Invitrogen) supplemented with mini-
mum essential amino acid (Invitrogen), 200 mM of L-
glutamine (Invitrogen) and N2 supplement (Invitrogen).
The N2 medium was composed of N1 medium supple-
mented with 20 ng/ml bFGF. The N3 medium was com-
posed of KO-DMEM supplemented with 1% FBS
(Hyclone) and B27 supplement (Invitrogen). NPCs were
immunostained with nestin, whereas successful differen-
tiation of neuronal cell types was confirmed by the
expression of neuron specific bIII tubulin and MAP2
[13].
Counting of TrES1 with nuclear aggregate and NIs
After immunostaining with mEM48, each sample was
examined and images were taken at different regions of
the culture. A total of three 35 mm dishes of differen-
tiated TrES1 at different differentiation stages (N2, N3-
1w and N3-4w) were used in this study. All images were
taken at the same magnification, and the total number
of cells in each image were counted and categorized as
those with nuclear staining with mEm48, and those with
nuclear staining that contained one to five, six to 10 and
more than 10 NIs.
Western Blot Analysis
Total proteins were extracted from TrES1 cells and
equal amounts (20-30 μg) of protein extract were loaded
into a 9% polyacrylamide gel (Bio-Rad). Following elec-
trophoresis, proteins were transferred onto a PVDF
membrane followed by blocking in 5% skim milk for
two hours. The membrane was then incubated with pri-
mary antibodies, mouse mEM48 (1:50), and g-tubulin
(1:2000; Sigma), followed by secondary antibody conju-
gated with peroxidase (Jackson Immuno Research
Laboratories) for detecting proteins with a Western
Lightning Chemiluminescence Reagent Plus.
(PerkinElmer).
In vivo differentiation of TrES1 and formation of teratoma
in SCID mice
Undifferentiated TrES1 cell clumps were collected
mechanically. TrES1 derived NPCs at N2 stage were col-
lected by brief treatment with 0.05% trypsin/EDTA
(Invitrogen) to produce single cell suspension. An esti-
m a t eo f1×1 0
5 undifferentiated TrES cells and NPCs
were resuspended in 5 ul of DPBS and implanted into
the striatum of SCID mice. At four to 10 weeks after
implantation, animals were euthanized, and the brain
was recovered for further analysis. All surgical and
animal procedures were approved by YNPRC/Emory
Animal Care and Biosafety Committees. For staining of
neuronal markers, the sections were incubated with pri-
mary antibodies (nestin, bIII tubulin, MAP2; Chemicon)
at 4°C over night followed by thorough washes. A sec-
ondary antibody conjugated with Alexa Red (Molecular
Probe) was used for detection of the primary antibodies.
DNA was counterstained with Hoechst 33342 (5 μg/ml).
The specimen was examined with an epifluorescent
microscope.
Immunhistochemical staining of mutant htt
Mice were anesthetized and perfused using 4% parafor-
maldehyde (PFA). Brain tissues were post-fixed in 4%
PFA overnight at 4°C, transferred to 30% sucrose at 4°C,
embedded in Optimal Cutting Temperature (OCT)
medium (Sakura), cut at 50 μm, followed by DAB stain-
ing. Sections were incubated with 0.3% H2O2 for 15
mins, blocked for 1 hr, and incubated with mEM48
(1:50) at 4°C overnight. After washing with DPBS, the
brain sections were processed with avidin-biotin using
the Vectastain Elite ABC kit (Vector Laboratories), and
immediately stained with DAB (Vector Laboratories) for
30-40 secs. Brain sections were mounted on the slides
with mounting media (Sigma), and images were exam-
ined and captured by MetaMorph software (Universal
Imaging).
Statistical analysis
Student t-test was used for statistical analysis. Differ-
ences of P < 0.05 were considered statistically
significant.
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